{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:38:11Z","timestamp":1789087091798,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Postmenopausal osteoporosis (POP) is a prevalent skeletal disease among elderly women. Previous study indicated that suppressor of cytokine signaling 3 (SOCS3) participates in the regulation of bone marrow stromal cell (BMSC) osteogenesis. Here, we further investigated the exact function and mechanism of SOCS3 in POP progression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>BMSCs were isolated from Sprague\u2013Dawley rats and treated with Dexamethasone (Dex). Alizarin Red staining and ALP activity assays were applied to assess the osteogenic differentiation of rat BMSCs under the indicated conditions. Osteogenic genes (ALP, OPN, OCN, COL1) mRNA levels were determined using quantitative RT-PCR. Luciferase reporter assay verified the interaction between SOCS3 and miR-218-5p. Rat models of POP were established in ovariectomized (OVX) rats to detect the in vivo effects of SOCS3 and miR-218-5p.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that silencing SOCS3 antagonized the suppressive effects of Dex on the osteogenic differentiation of BMSCs. SOCS3 was found to be targeted by miR-218-5p in BMSCs. The SOCS3 levels were negatively modulated by miR-218-5p in femurs of POP rats. MiR-218-5p upregulation promoted the BMSC osteogenic differentiation, while SOCS3 overexpression reversed the effects of miR-218-5p. Moreover, SOCS3 was highly expressed and miR-218-5p was downregulated in the OVX rat models, and silencing SOCS3 or overexpressing miR-218-5p alleviated POP in OVX rats by promoting osteogenesis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SOCS3 downregulation mediated by miR-218-5p increases osteoblast differentiation to alleviate POP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-023-03580-4","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T12:33:03Z","timestamp":1676982783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MiR-218-5p-dependent SOCS3 downregulation increases osteoblast differentiation inpostmenopausal osteoporosis"],"prefix":"10.1186","volume":"18","author":[{"given":"Qian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"issue":"5","key":"3580_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tem.2016.03.006","volume":"27","author":"F Rivadeneira","year":"2016","unstructured":"Rivadeneira F, M\u00e4kitie O. Osteoporosis and bone mass disorders: from gene pathways to treatments. Trends Endocrinol Metab. 2016;27(5):262\u201381.","journal-title":"Trends Endocrinol Metab"},{"issue":"10169","key":"3580_CR2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364\u201376.","journal-title":"Lancet"},{"issue":"1","key":"3580_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13018-021-02497-0","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):351.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"3580_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13018-021-02474-7","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16(1):318.","journal-title":"J Orthop Surg Res"},{"issue":"2","key":"3580_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116462","volume":"10","author":"M Yuasa","year":"2015","unstructured":"Yuasa M, et al. Dexamethasone enhances osteogenic differentiation of bone marrow- and muscle-derived stromal cells and augments ectopic bone formation induced by bone morphogenetic protein-2. PLoS ONE. 2015;10(2): e0116462.","journal-title":"PLoS ONE"},{"issue":"1","key":"3580_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1947603512455196","volume":"4","author":"EM Florine","year":"2013","unstructured":"Florine EM, et al. Effects of dexamethasone on mesenchymal stromal cell chondrogenesis and aggrecanase activity: comparison of agarose and self-assembling peptide scaffolds. Cartilage. 2013;4(1):63\u201374.","journal-title":"Cartilage"},{"issue":"6","key":"3580_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP van Staa","year":"2001","unstructured":"van Staa TP, et al. Epidemiology of fractures in England and Wales. Bone. 2001;29(6):517\u201322.","journal-title":"Bone"},{"issue":"3","key":"3580_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jbmr.262","volume":"26","author":"S Khosla","year":"2011","unstructured":"Khosla S, Melton LJ 3rd, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res. 2011;26(3):441\u201351.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"3580_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11914-004-0018-y","volume":"2","author":"P Selby","year":"2004","unstructured":"Selby P. Postmenopausal osteoporosis. Curr Osteoporos Rep. 2004;2(3):101\u20136.","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"3580_CR10","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1517\/14656566.6.11.1803","volume":"6","author":"AC Sasser","year":"2005","unstructured":"Sasser AC, et al. Assessing the economic impact of chronic conditions in postmenopausal women. Expert Opin Pharmacother. 2005;6(11):1803\u201314.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"3580_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.whi.2004.11.006","volume":"15","author":"AC Sasser","year":"2005","unstructured":"Sasser AC, et al. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues. 2005;15(3):97\u2013108.","journal-title":"Womens Health Issues"},{"issue":"1","key":"3580_CR12","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"3580_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, et al. Pharmacological management of postmenopausal osteoporosis: a level I evidence based\u2014expert opinion. Expert Rev Clin Pharmacol. 2021;14(1):105\u201319.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"3580_CR14","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jbmr.251","volume":"26","author":"R Eastell","year":"2011","unstructured":"Eastell R, et al. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res. 2011;26(3):530\u20137.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"3580_CR15","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/ijms16035452","volume":"16","author":"V Conti","year":"2015","unstructured":"Conti V, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy. Int J Mol Sci. 2015;16(3):5452\u201366.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3580_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/jcb.22262","volume":"108","author":"S Itoh","year":"2009","unstructured":"Itoh S, Aubin JE. A novel purification method for multipotential skeletal stem cells. J Cell Biochem. 2009;108(2):368\u201377.","journal-title":"J Cell Biochem"},{"issue":"8","key":"3580_CR17","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.3390\/ijms130810229","volume":"13","author":"S Itoh","year":"2012","unstructured":"Itoh S, et al. Bone marrow-derived HipOP cell population is markedly enriched in osteoprogenitors. Int J Mol Sci. 2012;13(8):10229\u201335.","journal-title":"Int J Mol Sci"},{"key":"3580_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114497","volume":"186","author":"YM Attia","year":"2021","unstructured":"Attia YM, et al. Activation of FXR modulates SOCS3\/Jak2\/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model. Biochem Pharmacol. 2021;186: 114497.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3580_CR19","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.bbrc.2003.08.068","volume":"309","author":"AC Lovibond","year":"2003","unstructured":"Lovibond AC, et al. TGF-beta-induced SOCS3 expression augments TNF-alpha-induced osteoclast formation. Biochem Biophys Res Commun. 2003;309(4):762\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3580_CR20","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1128\/IAI.01070-08","volume":"77","author":"X Zhang","year":"2009","unstructured":"Zhang X, et al. Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss. Infect Immun. 2009;77(5):2000\u20139.","journal-title":"Infect Immun"},{"key":"3580_CR21","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3389\/fimmu.2018.02641","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen Y, et al. Silencing SOCS3 markedly deteriorates spondyloarthritis in mice induced by minicircle DNA expressing IL23. Front Immunol. 2018;9:2641.","journal-title":"Front Immunol"},{"issue":"1","key":"3580_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bmb\/ldaa002","volume":"133","author":"L Giordano","year":"2020","unstructured":"Giordano L, et al. Therapeutic potential of microRNA in tendon injuries. Br Med Bull. 2020;133(1):79\u201394.","journal-title":"Br Med Bull"},{"issue":"1","key":"3580_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/bmb\/ldz015","volume":"130","author":"A Oliviero","year":"2019","unstructured":"Oliviero A, et al. MicroRNA in osteoarthritis: physiopathology, diagnosis and therapeutic challenge. Br Med Bull. 2019;130(1):137\u201347.","journal-title":"Br Med Bull"},{"issue":"1","key":"3580_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/bmb\/ldaa040","volume":"138","author":"G Gargano","year":"2021","unstructured":"Gargano G, et al. Small interfering RNAs in tendon homeostasis. Br Med Bull. 2021;138(1):58\u201367.","journal-title":"Br Med Bull"},{"issue":"1","key":"3580_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/bmb\/ldac012","volume":"142","author":"G Gargano","year":"2022","unstructured":"Gargano G, et al. Small interfering RNAs in the management of human rheumatoid arthritis. Br Med Bull. 2022;142(1):34\u201343.","journal-title":"Br Med Bull"},{"issue":"6","key":"3580_CR26","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/S1470-2045(12)70073-6","volume":"13","author":"YW Kong","year":"2012","unstructured":"Kong YW, et al. microRNAs in cancer management. Lancet Oncol. 2012;13(6):e249\u201358.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3580_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, et al. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297\u2013325.","journal-title":"Physiol Rev"},{"issue":"19","key":"3580_CR28","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1007\/s00018-019-03162-w","volume":"76","author":"D Bellavia","year":"2019","unstructured":"Bellavia D, et al. Deregulated miRNAs in osteoporosis: effects in bone metastasis. Cell Mol Life Sci. 2019;76(19):3723\u201344.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"3580_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/15476286.2014.996462","volume":"11","author":"P Tang","year":"2014","unstructured":"Tang P, et al. The role of microRNAs in osteoclasts and osteoporosis. RNA Biol. 2014;11(11):1355\u201363.","journal-title":"RNA Biol"},{"key":"3580_CR30","doi-asserted-by":"publisher","first-page":"100617","DOI":"10.1016\/j.jbc.2021.100617","volume":"66","author":"Y Huang","year":"2021","unstructured":"Huang Y, et al. miR-21\u20135p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis. J Biol Chem. 2021;66:100617.","journal-title":"J Biol Chem"},{"key":"3580_CR31","first-page":"1","volume":"66","author":"F Liu","year":"2021","unstructured":"Liu F, Liang Y, Lin X. MiR-151b inhibits osteoblast differentiation via downregulating Msx2. Connect Tissue Res. 2021;66:1\u201312.","journal-title":"Connect Tissue Res"},{"key":"3580_CR32","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.yexmp.2019.02.003","volume":"107","author":"H Hu","year":"2019","unstructured":"Hu H, et al. miR-26b modulates OA induced BMSC osteogenesis through regulating GSK3\u03b2\/\u03b2-catenin pathway. Exp Mol Pathol. 2019;107:158\u201364.","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"3580_CR33","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/jcb.29355","volume":"121","author":"J Kou","year":"2020","unstructured":"Kou J, et al. MicroRNA-218-5p relieves postmenopausal osteoporosis through promoting the osteoblast differentiation of bone marrow mesenchymal stem cells. J Cell Biochem. 2020;121(2):1216\u201326.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3580_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13287-018-0935-9","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen S, et al. DEPTOR regulates osteogenic differentiation via inhibiting MEG3-mediated activation of BMP4 signaling and is involved in osteoporosis. Stem Cell Res Ther. 2018;9(1):185.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"3580_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41419-020-2562-5","volume":"11","author":"JW Kim","year":"2020","unstructured":"Kim JW, et al. CUEDC2 controls osteoblast differentiation and bone formation via SOCS3-STAT3 pathway. Cell Death Dis. 2020;11(5):344.","journal-title":"Cell Death Dis"},{"issue":"7","key":"3580_CR36","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/jcb.24777","volume":"115","author":"K Matsushita","year":"2014","unstructured":"Matsushita K, et al. LIF\/STAT3\/SOCS3 signaling pathway in murine bone marrow stromal cells suppresses osteoblast differentiation. J Cell Biochem. 2014;115(7):1262\u20138.","journal-title":"J Cell Biochem"},{"issue":"2","key":"3580_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tripleo.2007.06.010","volume":"105","author":"G Giro","year":"2008","unstructured":"Giro G, et al. Influence of estrogen deficiency and its treatment with alendronate and estrogen on bone density around osseointegrated implants: radiographic study in female rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(2):162\u20137.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"3580_CR38","first-page":"424","volume":"58","author":"PP Lelovas","year":"2008","unstructured":"Lelovas PP, et al. The laboratory rat as an animal model for osteoporosis research. Comp Med. 2008;58(5):424\u201330.","journal-title":"Comp Med"},{"issue":"12","key":"3580_CR39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"3580_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.gde.2005.01.002","volume":"15","author":"AE Pasquinelli","year":"2005","unstructured":"Pasquinelli AE, Hunter S, Bracht J. MicroRNAs: a developing story. Curr Opin Genet Dev. 2005;15(2):200\u20135.","journal-title":"Curr Opin Genet Dev"},{"key":"3580_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bone.2019.02.013","volume":"122","author":"D Bellavia","year":"2019","unstructured":"Bellavia D, et al. Deregulated miRNAs in bone health: epigenetic roles in osteoporosis. Bone. 2019;122:52\u201375.","journal-title":"Bone"},{"issue":"17","key":"3580_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/ijms21176081","volume":"21","author":"Y Gao","year":"2020","unstructured":"Gao Y, Patil S, Qian A. The role of MicroRNAs in bone metabolism and disease. Int J Mol Sci. 2020;21(17):66.","journal-title":"Int J Mol Sci"},{"key":"3580_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bone.2013.09.015","volume":"58","author":"WB Zhang","year":"2014","unstructured":"Zhang WB, Zhong WJ, Wang L. A signal-amplification circuit between miR-218 and Wnt\/\u03b2-catenin signal promotes human adipose tissue-derived stem cells osteogenic differentiation. Bone. 2014;58:59\u201366.","journal-title":"Bone"},{"issue":"24","key":"3580_CR44","first-page":"5534","volume":"21","author":"WW Wang","year":"2017","unstructured":"Wang WW, et al. The function of miR-218 and miR-618 in postmenopausal osteoporosis. Eur Rev Med Pharmacol Sci. 2017;21(24):5534\u201341.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-03580-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T12:33:09Z","timestamp":1676982789000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-03580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3580"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-03580-4","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in animal experiments were performed following the NIH Guides for the Care and Use of Laboratory Animals and were approved by the Ethics Committee of Huangshi Central Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}